Announcements Trials

Browse Landscape

Sponsor

Conditions

Pancreatic Neoplasms 2 Lung Neoplasms 2 Barrett Esophagus 2 Triple Negative Breast Neoplasms 1 Thyroid Nodule 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Neoplasm Metastasis 1 Liver Cirrhosis 1 Hypertension, Portal 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Cysts 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Calcinosis 1 Breast Neoplasms 1 Breast Cyst 1 Arachnodactyly 1 Adenocarcinoma of Lung 1

Interventions

Magnetic Resonance Spectroscopy 10 trametinib 7 Nivolumab 7 selpercatinib 6 pembrolizumab 6 dabrafenib 6 Iodine-131 6 Specimen Handling 5 Biopsy 5 lenvatinib 4 Vemurafenib 4 Iodine-124 4 durvalumab 3 cabozantinib 3 binimetinib 3 Ipilimumab 3 Immunoglobulin G 3 Fluorodeoxyglucose F18 3 Disulfides 3 Cyclophosphamide 3 Cetuximab 3 vandetanib 2 ulixertinib 2 omipalisib 2 larotrectinib 2 defactinib 2 copanlisib 2 cemiplimab 2 anlotinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Neoplasms × Diagnostic Imaging × 1 year × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡